ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ACROMEC's associated Life Science Incubator launches Co-working Labspace

SINGAPORE, Sept 24, 2021 - (ACN Newswire) - ACROMEC Limited (ACROMEC; SGX: 43F), a specialist engineering services provider, announced that subsidiary ACROMEC Engineers Pte Ltd (ACROMEC Engineers) through joint-venture associate Life Science Incubator Pte Ltd, has launched the first Life Science Incubator co-working laboratory space, with a ceremony on location at the German Centre, International Business Plaza, Singapore.

The ceremony was attended by Mr. Alvin Tan, Minister of State, Ministry of Culture, Community and Youth and Ministry of Trade & Industry, and others from the Economic Development Board, Enterprise Singapore, SGInnovate, A*STAR, NTUitiv and NUS accelerator. Members of Life Science Incubator's current network of some 20 industry partners, including Merck, also attended the event.

Serving early-stage bio and pharma start-ups, companies and entrepreneurs in the MedTech, Biotech, Biopharma and FoodTech sectors, Life Science Incubator will provide flexible co-working laboratory spaces for research and development. With access to communal state-of-the-art technologies and facilities, start-ups will be able to fully focus on innovation and talent in science without having to think about hefty infrastructure capital.

Said Niamh Madden, General Manager of Life Science Incubator, "Today marks the start of our exciting journey at the Life Science Incubator. We look forward to supporting science and technology start-ups and being an integral launchpad for their endeavours. With our strong network of partner companies, we are confident that the incubator will become a vibrant centre of entrepreneurship, technology and science."

Said Mr Lim Say Chin, Executive Chairman and Managing Director of ACROMEC, "The successful completion and launch of the Life Science Incubator attests to ACROMEC's track record and success as a specialist engineering provider for controlled environments. We are excited to be a part of this vibrant ecosystem and will continue to serve companies and start-ups in the life science, biotech, healthcare, and research sectors."

In July, the Group announced that wholly-owned subsidiary ACROMEC Engineers had entered into a joint-venture agreement with strategic partner Tako Ventures to build, own, and operate JVCo and co-working laboratory facilities. JVCo is 30% owned by the Group through ACROMEC Engineers, while Tako Ventures holds the remaining 70% stake, managing JVCo and the Life Science Incubator.

ACROMEC Engineers undertook the design, construction, and fitting-out works for the 600 square meter Life Science Incubator's co-working laboratory facilities, which includes 8 suites, 51 lab benches, and 1 operating theatre.

About ACROMEC Limited
SGX Catalyst-listed ACROMEC (SGX: 43F) is an established specialist engineering services provider with more than 20 years in the field of controlled environments. The Group has acquired expertise in the design and construction of facilities requiring controlled environments such as laboratories, medical and sterile facilities and cleanrooms. Amongst its customers, ACROMEC counts hospitals & medical centres, government agencies, educational institutions, research & development companies and multinational units, pharmaceutical, semiconductor manufacturing and engineering companies. For more information, visit www.acromec.com.

ACROMEC share information through SGX (43F), Bloomberg (ACRO.SG) and ThomsonReuters (ACRO.SI).

Analyst & Media contact:
ACROMEC Limited
Mr Jerry Tan, CFO
E: jerry.tan@acromec.com

Waterbrooks Consultants Pte Ltd
Mr Wayne Koo / Ms Raihana
T: +65 6958 8002 / +65 9338 8166
E: wayne.koo@waterbrooks.com.sg / raihana@waterbrooks.com.sg


Source: Life Sciences IncubatorACROMEC Engineers

Copyright 2021 ACN Newswire . All rights reserved.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.